SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Revises Process for Responding to Drug Applications

July 28, 2008 | 
1 min read
The U.S. Food and Drug Administration today announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Cancer of the brain as tumor growth diagnosis and symptoms of gliomas meningiomas astrocytomas and oligodendrogliomas as diagnosis of symptoms as a paper sculpture.
Alzheimer’s disease
Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use
October 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Same goal. Two businesses on the growth graph. vector
FDA
Consistency in the Chaos: FDA Approvals Within Average Range as Q4 Kicks Off
October 13, 2025
 · 
4 min read
 · 
Heather McKenzie
People determined to be free, freedom and confinement vector art
Rare diseases
Nearly Three Quarters of FDA Breakthrough Designated Drugs Win Approval: Report
October 9, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Pictured: Boehringer Ingelheim sign on a building/
Approvals
Boehringer Ingelheim Breaks Decade-Long Approval Drought in Idiopathic Pulmonary Fibrosis
October 8, 2025
 · 
2 min read
 · 
Tristan Manalac